Agitation in Dementia
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease (NCT07422311) | Benuvia Therapeutics Inc. | 2026-05-01 |
| Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease. (NCT06781333) | Bernard (Barry) Baumel | 2025-04-29 |
Track Agitation in Dementia automatically
Every clearance here is in the API, with alerts when new ones post.